Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

China flag China · Delayed Price · Currency is CNY
4.470
+0.030 (0.68%)
Apr 29, 2026, 3:00 PM CST
-1.97%
Market Cap 11.34B
Revenue (ttm) 6.69B
Net Income (ttm) 483.42M
Shares Out 2.54B
EPS (ttm) 0.19
PE Ratio 23.13
Forward PE n/a
Dividend 0.15 (3.38%)
Ex-Dividend Date Jun 25, 2025
Volume 50,630,330
Average Volume 91,116,600
Open 4.420
Previous Close 4.440
Day's Range 4.410 - 4.480
52-Week Range 4.040 - 5.170
Beta 0.30
RSI 48.58
Earnings Date Apr 23, 2026

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio... [Read more]

Sector Healthcare
Founded 1969
Employees 8,411
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600572
Full Company Profile

Financial Performance

In 2025, SHA:600572's revenue was 6.47 billion, a decrease of -0.64% compared to the previous year's 6.52 billion. Earnings were 474.36 million, a decrease of -23.79%.

Financial Statements

News

There is no news available yet.